Eiken Chemical Past Earnings Performance
Past criteria checks 2/6
Eiken Chemical has been growing earnings at an average annual rate of 8.1%, while the Medical Equipment industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 4.4% per year. Eiken Chemical's return on equity is 5.9%, and it has net margins of 7.4%.
Key information
8.1%
Earnings growth rate
8.0%
EPS growth rate
Medical Equipment Industry Growth | 7.8% |
Revenue growth rate | 4.4% |
Return on equity | 5.9% |
Net Margin | 7.4% |
Next Earnings Update | 09 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Eiken Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 39,904 | 2,946 | 9,086 | 4,065 |
30 Sep 23 | 40,670 | 3,033 | 9,719 | 4,065 |
30 Jun 23 | 42,038 | 4,337 | 9,364 | 4,065 |
31 Mar 23 | 43,271 | 5,736 | 8,984 | 4,065 |
31 Dec 22 | 45,025 | 6,543 | 9,909 | 3,408 |
30 Sep 22 | 44,520 | 6,873 | 9,107 | 3,408 |
30 Jun 22 | 43,579 | 6,413 | 8,908 | 3,408 |
31 Mar 22 | 42,996 | 6,218 | 8,776 | 3,408 |
31 Dec 21 | 41,951 | 5,796 | 9,254 | 3,086 |
30 Sep 21 | 42,281 | 6,559 | 9,024 | 3,086 |
30 Jun 21 | 40,967 | 6,254 | 8,888 | 3,086 |
31 Mar 21 | 38,667 | 5,044 | 8,828 | 3,086 |
31 Dec 20 | 37,104 | 4,487 | 8,123 | 3,332 |
30 Sep 20 | 35,395 | 3,345 | 8,178 | 3,332 |
30 Jun 20 | 35,567 | 3,171 | 8,182 | 3,332 |
31 Mar 20 | 36,585 | 3,538 | 8,276 | 3,332 |
31 Dec 19 | 36,722 | 3,551 | 8,438 | 2,904 |
30 Sep 19 | 37,036 | 3,822 | 8,264 | 2,904 |
30 Jun 19 | 36,177 | 3,592 | 8,170 | 2,904 |
31 Mar 19 | 35,761 | 3,447 | 8,176 | 2,904 |
31 Dec 18 | 35,522 | 3,303 | 8,078 | 3,238 |
30 Sep 18 | 35,171 | 2,944 | 8,088 | 3,238 |
30 Jun 18 | 35,087 | 2,773 | 8,054 | 3,238 |
31 Mar 18 | 34,991 | 2,608 | 7,982 | 3,238 |
31 Dec 17 | 34,558 | 2,980 | 8,061 | 2,336 |
30 Sep 17 | 33,932 | 2,836 | 8,061 | 2,336 |
30 Jun 17 | 33,740 | 2,964 | 7,953 | 2,336 |
31 Mar 17 | 33,274 | 2,918 | 7,850 | 2,336 |
31 Dec 16 | 33,188 | 3,024 | 7,782 | 2,272 |
30 Sep 16 | 32,670 | 2,882 | 7,716 | 2,272 |
30 Jun 16 | 32,586 | 2,587 | 7,627 | 2,272 |
31 Mar 16 | 32,163 | 2,429 | 7,594 | 2,272 |
31 Dec 15 | 31,727 | 2,389 | 7,330 | 2,456 |
30 Sep 15 | 31,492 | 2,013 | 7,617 | 2,456 |
30 Jun 15 | 31,180 | 2,152 | 7,666 | 2,456 |
31 Mar 15 | 31,014 | 2,100 | 7,585 | 2,456 |
31 Dec 14 | 30,750 | 1,877 | 8,087 | 1,945 |
30 Sep 14 | 30,781 | 2,248 | 7,616 | 1,945 |
30 Jun 14 | 30,135 | 1,986 | 7,493 | 1,945 |
31 Mar 14 | 30,027 | 1,984 | 7,422 | 1,945 |
31 Dec 13 | 29,311 | 2,569 | 7,447 | 1,840 |
30 Sep 13 | 29,072 | 2,545 | 7,289 | 1,840 |
30 Jun 13 | 28,764 | 2,474 | 7,238 | 1,840 |
Quality Earnings: 4549 has high quality earnings.
Growing Profit Margin: 4549's current net profit margins (7.4%) are lower than last year (14.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4549's earnings have grown by 8.1% per year over the past 5 years.
Accelerating Growth: 4549's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4549 had negative earnings growth (-55%) over the past year, making it difficult to compare to the Medical Equipment industry average (4.1%).
Return on Equity
High ROE: 4549's Return on Equity (5.9%) is considered low.